Langsung ke konten utama

Itunes: He Who Plays The Piper Makes A Loss

The Register reports that iTunes, the Apple “legitimate” music downloading service is losing money. This is because much of the 99c per vocal fee goes inwards the shape of licence fees to RIAA. On superlative of this, Apple had to educate the software that powers the downloading as well as to hold the downloading site. The companionship plans to brand a turn a profit yesteryear associated hardware tie-ins, similar its iPod quaff music players. The Register criticises Apple’s approach, shout out for why it is “helping an extinct, as well as unworthy manufacture dorsum on its feet” as well as helping “ancient copyright rules spin the coin dorsum to the pigopolists”, rather than supporting a compulsory licence system where all artists are paid a apartment charge per unit of measurement for their performances. It concludes that the argue is that, inwards the interests of vanity, Apple is bully to survive the offset successful legal download company.

While the IPKat is disappointed that Apple is non breaking fifty-fifty inwards running its service, he isn’t certain that he agrees alongside The Register’s analysis of Apple’s approach. Whether or non a compulsory licence system of the variety the article advocates is desirable, at acquaint the copyright laws require the payment of licence fees as well as Apple is providing a valuable service inwards running a legal downloading facility as well as thence filling a need inwards the marketplace that was non adequately catered for.

iTunes here
i Claudius here
i For an Eye here


Komentar

Postingan populer dari blog ini

Something To Read This Weekend

July-August Copyright World The electrical flow termination of Informa's colourful Copyright World has only reached the IPKat. The comprehend story is Google v Rest of the World - at least, it must experience that means to the giant moneymaker every bit it seeks to induce got on a vast array of vested interests inwards mature markets as well as technologies amongst its controversial Library Project. bets that this topic volition attain saturation point, replacing fifty-fifty P2P filesharing every bit the boringly predictable PhD thesis topic that all candidates desire to write. Full listing of contents here . Merpel's Must-Read : "Into the Honey Trap?", where the Copyright Terminator meets Winnie the Pooh. July-August MIP The July-August termination of Euromoney's Managing Intellectual Property lists the 50 close influential IP personalities of the year. Alas, afterwards the excitement of making the listing concluding fourth dimension round, the IPKat has been ...

No Prophylactic Trend To Intermission Up; Latest Ecdr

No rubber agency to interruption up This morning time the IPKat carried a greenback on Scansafe Ltd 5 Messagelabs Ltd , a Chancery Division conclusion from Mr Justice Patten which was noted on Lawtel. has since received an electronic mail from solicitors acting on behalf of Scansafe, informing him that the Lawtel greenback erroneously stated that Scansafe's application for injunctive relief was dismissed. Lawtel has since withdrawn its greenback in addition to the IPKat, non wishing to mislead his readers, has removed his greenback on the example too. Latest ECDR Issue four of the Sweet & Maxwell bimonthly European Copyright in addition to Design Reports has at i time been published. Cases available inwards English linguistic communication inwards this lawsuit include * L'Oréal SA 5 Bellure NV (Cour d'appel de Paris), on the protection of scents inwards French Republic every bit authors' works; * PlayStation (Tribunal of Bolzano, Italy), on the seizure of modern...

Gsk Gets That Ill Feeling Equally Antibiotic Patents Come Across An Early On Death

GlaxoSmithKline ( lost its activity to forbid Swiss fellowship Novartis making in addition to selling inexpensive generic versions of Augmentin , GSK's leading antibiotic. GSK’s proceedings were aimed both against Novartis in addition to its generic company, Geneva Pharmaceuticals . The United States Court of Appeals for the Federal Circuit ruled inwards favour of Novartis in addition to Geneva slow on Friday, upholding Geneva's claim that vii of GSK's patents for the drug were "improper in addition to should non bring been used to extend patent protection for [GSK's] product". Novartis in addition to Geneva surprised the marketplace inwards 2002 when it launched a generic version of Augmentin. The launch came afterwards an unexpected United States legal determination inwards May 2002 that a position out of GSK's patents for Augmentin were invalid. GSK spent over a twelvemonth fighting the determination only the master copy ruling has straight off bee...